Patient Information
Gastro 2009: Public Information Event
Do you suffer from a gut condition?
Would you like more information on how to live with and treat the condition?
Free Invitation!
At London’s ExCel Centre on Sunday 22nd November 2009 at 1.30p.m. there will be a public information event where you can find out more about chronic gut conditions, such as Irritable Bowel Syndrome, Inflammatory Bowel Disease and Coeliac Disease.
Chaired by broadcaster and author, Dr. Mark Porter, this information event provides a great opportunity to hear from world renowned experts on the latest medical opinion and research, diagnosis and management and how to live with and take control of chronic gut conditions.
- Download Event Flyer [ 2.3 Mb ]
Information for Patients
Here you will find patient information about a range of conditions affecting the gut and liver.
- Bowel Cancer
- Liver Cancer
- Oesophageal cancer
- Pancreatic cancer
- Stomach cancer
- Coeliac Disease
- Ulcerative Colitis
- Constipation
- Crohn’s disease
- Acute diarrhoea
- Diverticular disease
- Faecal incontinence
- Gallstones
- Heartburn
- Helicobacter Pylori
- Indigestion
- Irritable Bowel Syndrome
- Looking after your insides
- Peptic ulcers
- Perianal diseases
- Polyps in the bowel
- Windy symptoms
This information is published by Core – the Digestive Disorders Foundation in association with the British Society of Gastroenterology and the Primary Care Society for Gastroenterology. This following web page are provided for information only. The information found is not a substitute for professional medical care by a qualified doctor or other health care professional. ALWAYS check with your doctor if you have any concerns about your condition or treatment. The publishers are not responsible or liable, directly or indirectly, for ANY form of damages whatsoever resulting from the use (or misuse) of information contained in or implied by the information in this booklet.
Disease Modifying Drugs in Inflammatory Bowel Disease (IBD):
The following leaflets are designed to provide information for patients with IBD regarding the use of disease modifying drugs, their indications, side effects and guidelines for safe monitoring. This document does not cover the use of biological agents whose use is considered elsewhere.